Common Contracts
2 similar Participant Information and Agreement contracts
PARTICIPANT INFORMATION AND AGREEMENT TO TAKE PART FORMParticipant Information and Agreement • June 1st, 2021
Administrative information: Universal trial number: U1111-1201-6256 EudraCT number: 2017-003619-20 Version: 3.0 US Final Official name of the study:Long-term effects of semaglutide on diabetic retinopathy in patients with type 2 diabetes (FOCUS) Research sponsor contact information: Novo Nordisk A/S, Novo Allé, 2880 Bagsvaerd, Denmark A description of this clinical trial will be available on http://www.ClinicalTrials.gov, as required byU.S. Law. This Web site will not include information that can identify you. At most, the Web site will include a summary of the results. You can search this Web site at any time. Information about the study and the results will also be made available at www.novonordisk- trials.com, www.clinicaltrialsregister.eu and potentially in other regional or local registries
PARTICIPANT INFORMATION AND AGREEMENT TO TAKE PART FORMParticipant Information and Agreement • May 20th, 2020
Administrative information: Universal trial number: U1111-1201-6256 EudraCT number: 2017-003619-20 Version: 3.0 US Final Official name of the study:Long-term effects of semaglutide on diabetic retinopathy in patients with type 2 diabetes (FOCUS) Research sponsor contact information: Novo Nordisk A/S, Novo Allé, 2880 Bagsvaerd, Denmark A description of this clinical trial will be available on http://www.ClinicalTrials.gov, as required byU.S. Law. This Web site will not include information that can identify you. At most, the Web site will include a summary of the results. You can search this Web site at any time. Information about the study and the results will also be made available at www.novonordisk- trials.com, www.clinicaltrialsregister.eu and potentially in other regional or local registries
